BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36570276)

  • 1. Mechanistic Study of Diketopiperazine Formation during Solid-Phase Peptide Synthesis of Tirzepatide.
    Wang J; Berglund MR; Braden T; Embry MC; Johnson MD; Groskreutz SR; Sayyed FB; Tsukanov SV; White TD; Jalan A; Seibert KD; Kopach ME
    ACS Omega; 2022 Dec; 7(50):46809-46824. PubMed ID: 36570276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Fmoc-Removal Strategy to Suppress the Traceless and Conventional Diketopiperazine Formation in Solid-Phase Peptide Synthesis.
    Yang Y; Hansen L
    ACS Omega; 2022 Apr; 7(14):12015-12020. PubMed ID: 35449974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of unexpected protecting group removal in solid-phase peptide synthesis: Quantified using continuous flow methods.
    Laude V; Nuño M; Moses RC; Guthrie D
    J Pept Sci; 2022 Dec; 28(12):e3441. PubMed ID: 35785412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asparagine coupling in Fmoc solid phase peptide synthesis.
    Gausepohl H; Kraft M; Frank RW
    Int J Pept Protein Res; 1989 Oct; 34(4):287-94. PubMed ID: 2599767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility study of Merrifield linker in Fmoc strategy peptide synthesis.
    Yang X; Lin H; Lu W; Wang D
    Protein Pept Lett; 2013 Feb; 20(2):140-5. PubMed ID: 22894150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Fmoc/solid-phase synthesis of Abu(P)-containing peptides using Fmoc-Abu(PO3Me2)-OH.
    Perich JW
    Int J Pept Protein Res; 1994 Sep; 44(3):288-94. PubMed ID: 7822106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Related impurities in peptide medicines.
    D'Hondt M; Bracke N; Taevernier L; Gevaert B; Verbeke F; Wynendaele E; De Spiegeleer B
    J Pharm Biomed Anal; 2014 Dec; 101():2-30. PubMed ID: 25044089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regeneration of aged DMF for use in solid-phase peptide synthesis.
    Magtaan JK; Devocelle M; Kelleher F
    J Pept Sci; 2019 Jan; 25(1):e3139. PubMed ID: 30585396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of N Terminus Amino Acid on Peptide Cleavage in Solution through Diketopiperazine Formation.
    Zhang ZC; Hales DA; Clemmer DE
    J Am Soc Mass Spectrom; 2022 Aug; 33(8):1368-1376. PubMed ID: 35576623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
    Luna OF; Gomez J; Cárdenas C; Albericio F; Marshall SH; Guzmán F
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27854291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HPLC-ESMS study on the solid-phase assembly of C-terminal proline peptides.
    Chiva C; Vilaseca M; Giralt E; Albericio F
    J Pept Sci; 1999 Mar; 5(3):131-40. PubMed ID: 10323557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morpholine, a strong contender for Fmoc removal in solid-phase peptide synthesis.
    Mthembu SN; Chakraborty A; Schönleber R; Albericio F; de la Torre BG
    J Pept Sci; 2024 Feb; 30(2):e3538. PubMed ID: 37609959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of diketopiperazine formation using model peptides.
    Goolcharran C; Borchardt RT
    J Pharm Sci; 1998 Mar; 87(3):283-8. PubMed ID: 9523979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing aspartimide formation in Fmoc SPPS of Asp-Gly containing peptides--practical aspects of new trialkylcarbinol based protecting groups.
    Behrendt R; Huber S; White P
    J Pept Sci; 2016 Feb; 22(2):92-7. PubMed ID: 26751703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racemisation of N-Fmoc phenylglycine under mild microwave-SPPS and conventional stepwise SPPS conditions: attempts to develop strategies for overcoming this.
    Elsawy MA; Hewage C; Walker B
    J Pept Sci; 2012 May; 18(5):302-11. PubMed ID: 22451378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient solid phase synthesis of mixed Thr(P)-, Ser(P)- and Tyr(P)-containing phosphopeptides by "global" "phosphite-triester" phosphorylation.
    Perich JW
    Int J Pept Protein Res; 1992 Aug; 40(2):134-40. PubMed ID: 1280250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxy-4-methylsulfinylbenzyl Alcohol as a Safety-Catch Linker for the Fmoc/
    Nandhini KP; Albericio F; de la Torre BG
    J Org Chem; 2022 Aug; 87(15):9433-9442. PubMed ID: 35801570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fmoc/solid-phase synthesis of Tyr(P)-containing peptides through t-butyl phosphate protection.
    Perich JW; Reynolds EC
    Int J Pept Protein Res; 1991 Jun; 37(6):572-5. PubMed ID: 1717394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making Ends Meet: Microwave-Accelerated Synthesis of Cyclic and Disulfide Rich Proteins Via In Situ Thioesterification and Native Chemical Ligation.
    Gunasekera S; Aboye TL; Madian WA; El-Seedi HR; Göransson U
    Int J Pept Res Ther; 2013 Mar; 19(1):43-54. PubMed ID: 23504256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.